Teladoc Health (TDOC) Set to Announce Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of ($0.35) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Teladoc Health Stock Performance

NYSE:TDOC opened at $9.57 on Tuesday. The firm’s fifty day moving average price is $10.10 and its 200 day moving average price is $13.93. Teladoc Health has a 1-year low of $8.73 and a 1-year high of $30.15. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The firm has a market cap of $1.62 billion, a price-to-earnings ratio of -6.79 and a beta of 0.94.

Analyst Ratings Changes

Several brokerages have commented on TDOC. Bank of America decreased their target price on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a research report on Tuesday, May 14th. Royal Bank of Canada decreased their target price on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, April 26th. Canaccord Genuity Group decreased their target price on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, April 26th. Evercore ISI cut their price target on Teladoc Health from $14.00 to $10.00 and set an “in-line” rating for the company in a research note on Tuesday, July 9th. Finally, Wells Fargo & Company cut their price target on Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating for the company in a research note on Monday, April 29th. Thirteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $17.97.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the transaction, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the sale, the insider now directly owns 86,070 shares of the company’s stock, valued at approximately $1,092,228.30. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Michael Willem Waters sold 5,793 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $73,513.17. Following the sale, the chief operating officer now directly owns 64,881 shares in the company, valued at $823,339.89. The disclosure for this sale can be found here. In the last quarter, insiders sold 31,592 shares of company stock worth $383,854. 0.95% of the stock is currently owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.